Optimising the design of phase II oncology trials: The importance of randomisation
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference22 articles.
1. Learning versus confirming in clinical drug development;Sheiner;Clin Pharmacol Ther,1997
2. Predicting the outcome of phase III trials using phase II data: a case study of clinical trial simulation in late stage drug development;De Ridder;Basic Clin Pharmacol Toxicol,2005
3. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent;Gehan;J Chronic Dis,1961
4. Incorporating toxicity considerations into the design of two-stage phase II clinical trials;Bryant;Biometrics,1995
5. Designs for group sequential phase II clinical trials;Chang;Biometrics,1987
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Two-stage response adaptive randomization designs for multi-arm trials with binary outcome;Journal of Biopharmaceutical Statistics;2023-07-15
2. Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16);Journal of Clinical Oncology;2023-07-10
3. BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trials;Clinical Trials;2023-06-14
4. A Systematic Review and Pooled Analysis of Hypothesized versus Observed Effect Sizes in Early Phase Cancer Prevention Clinical Trials;Cancer Prevention Research;2023-05-31
5. Evolution of Phase II Oncology Trial Design: from Single Arm to Master Protocol;Therapeutic Innovation & Regulatory Science;2023-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3